Medscape covers trevogrumab, which it says reduced muscle loss during GLP-1 treatment and helped with weight regain afterward. Tap through for the trial details.
Recap by typeshit. Full story at Medscape.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Drugwatch, run by a law firm, reports nearly 250 NAION cases in Pennsylvania federal court. Relkin, co-lead counsel in New Jersey, argues for an eye exam before starting a GLP-1.
Fat and collagen loss drive the hollow look, specialists say, and early research hints GLP-1s may act on skin cells directly. Fillers and lasers are among the options.
Loading…